A Multicenter, Double-Blind, Double-Dummy, Randomized Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures With or Without Secondary Generalization.
Phase of Trial: Phase II
Latest Information Update: 25 Feb 2010
At a glance
- Drugs Lacosamide; Lacosamide
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors UCB
- 04 Dec 2008 New trial record.